Fintel reports that on May 21, 2025, Deutsche Bank upgraded their outlook for ACADIA Pharmaceuticals (NasdaqGS:ACAD) from Hold to Buy. Analyst Price Forecast Suggests 13.02% Upside As of May 6, 2025, ...

In this article, we are going to take a look at where ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) stands against other Friday’s top performers. The stock market finished the trading week in the ...

ACADIA PHARMACEUTICALS ($ACAD) posted quarterly earnings results on Wednesday, May 7th. The company reported earnings of $0.11 per share, missing estimates of $0.11 ...

In other recent news, Acadia Pharmaceuticals reported a strong financial performance for the fourth quarter of 2024, with revenue increasing by 12% year-over-year to $259.6 million.

George Demos, 64, formerly of Acadia Pharmaceuticals Inc., admitted ... guilty today to a federal securities fraud count for insider trading. George Demos, 64, formerly of Acadia Pharmaceuticals ...

Acadia Pharmaceuticals director Elizabeth Garofalo sells $89,673 in stock ...

Elizabeth A. Garofalo, a director at Acadia Pharmaceuticals Inc. (NASDAQ: ACAD), recently sold 4,919 shares of the company’s common stock.The shares were sold at a price of $18.23 each, totaling ...

Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.

The latest update on Wednesday morning shows ACADIA Pharmaceuticals shares up by 0.39%, trading at $15.63 ... investors should approach insider transactions as part of a comprehensive analysis ...

Insider Sale: CEO Stephen Davis Sells Shares of ACADIA Pharmaceuticals Inc (ACAD) Shares of ACADIA Pharmaceuticals Inc were trading at $16.94 on the day of the transaction. The company has a ...

That’s an increase over the stock’s daily average trading volume of nearly 1 million shares. Acadia Pharmaceuticals is a pharmaceutical company focused on the development and commercialization ...

Is it smart to be bullish on ACADIA Pharmaceuticals Inc. (NASDAQ ... Equally as key, optimistic insider trading sentiment is another way to look at the marketplace. There are lots of motivations ...